Expression and regulation of interleukin-33 in human monocytes
Open Access
- 11 January 2010
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 130 (2), 172-180
- https://doi.org/10.1111/j.1365-2567.2009.03221.x
Abstract
Interleukin-33 (IL-33) is an IL-1 family cytokine that has a role in regulating T helper type 2 cytokines and mast cell development. Expression of IL-33 is also associated with chronic inflammatory conditions such as rheumatoid arthritis. However, there is little information regarding IL-33 in myeloid cell immune responses, which are important in immunity and inflammation. We therefore investigated the expression, intracellular location and regulation of myeloid cell IL-33 by lipopolysaccharide (LPS) from Escherichia coli and the periodontal pathogen Porphyromonas gingivalis. We detected IL-33 messenger RNA in the human promonocytic cell line THP-1, in monocytes derived from these cells and in primary human monocytes. However, IL-33 was not expressed in primary monocyte-derived dendritic cells. Stimulation of monocytes with E. coli LPS (Toll-like receptor 4 agonist) and LPS from P. gingivalis (Toll-like receptor 2 agonist) up-regulated IL-33 at both the messenger RNA and protein levels but IL-1β and tumour necrosis factor-α had no effect. The IL-33 protein was mainly found in the cytoplasm of monocytes with no evidence of nuclear translocation in stimulated cells. Furthermore, no IL-33 secretion was detected after stimulation with LPS and/or ATP. These data indicate that the function, if any, of IL-33 in activated monocytes is primarily intracellular. Interestingly, immunofluorescence analysis indicated that IL-33 was sequestered in the nucleus of monocytes undergoing apoptosis but released into the extracellular milieu by LPS-stimulated cells in which necrosis had been induced by freeze–thawing. Therefore, this endorses the view that IL-33 may function as an ‘alarmin’ and have a role in signalling cellular damage and inflammatory disease pathogenesis through release from damaged or necrotic cells.Keywords
This publication has 37 references indexed in Scilit:
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences of the United States of America, 2009
- Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritisArthritis & Rheumatism, 2009
- Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharideClinical and Experimental Immunology, 2009
- An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 ReceptorPublished by The American Association of Immunologists ,2008
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?PLOS ONE, 2008
- VIP InhibitsPorphyromonas gingivalisLPS-induced Immune Responses in Human MonocytesJournal of Dental Research, 2005
- HMGB1 is an endogenous immune adjuvant released by necrotic cellsEMBO Reports, 2004
- T1/ST2—an IL-1 receptor-like modulator of immune responsesCytokine & Growth Factor Reviews, 2004
- Molecular Characterization of NF-HEV, a Nuclear Factor Preferentially Expressed in Human High Endothelial VenulesThe American Journal of Pathology, 2003
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002